全文获取类型
收费全文 | 239902篇 |
免费 | 44471篇 |
国内免费 | 11334篇 |
专业分类
耳鼻咽喉 | 3517篇 |
儿科学 | 4488篇 |
妇产科学 | 3754篇 |
基础医学 | 16266篇 |
口腔科学 | 7768篇 |
临床医学 | 46022篇 |
内科学 | 41686篇 |
皮肤病学 | 4894篇 |
神经病学 | 17274篇 |
特种医学 | 8515篇 |
外国民族医学 | 59篇 |
外科学 | 28947篇 |
综合类 | 31776篇 |
现状与发展 | 79篇 |
一般理论 | 10篇 |
预防医学 | 26746篇 |
眼科学 | 6171篇 |
药学 | 17615篇 |
254篇 | |
中国医学 | 11409篇 |
肿瘤学 | 18457篇 |
出版年
2024年 | 1299篇 |
2023年 | 7189篇 |
2022年 | 6770篇 |
2021年 | 9863篇 |
2020年 | 11101篇 |
2019年 | 6300篇 |
2018年 | 11194篇 |
2017年 | 12130篇 |
2016年 | 11955篇 |
2015年 | 14803篇 |
2014年 | 18647篇 |
2013年 | 20443篇 |
2012年 | 16276篇 |
2011年 | 16858篇 |
2010年 | 16892篇 |
2009年 | 17459篇 |
2008年 | 12769篇 |
2007年 | 11405篇 |
2006年 | 11544篇 |
2005年 | 9372篇 |
2004年 | 6182篇 |
2003年 | 5492篇 |
2002年 | 4629篇 |
2001年 | 4721篇 |
2000年 | 3694篇 |
1999年 | 3701篇 |
1998年 | 3265篇 |
1997年 | 3091篇 |
1996年 | 2845篇 |
1995年 | 2471篇 |
1994年 | 1803篇 |
1993年 | 1368篇 |
1992年 | 1167篇 |
1991年 | 1040篇 |
1990年 | 847篇 |
1989年 | 789篇 |
1988年 | 754篇 |
1987年 | 609篇 |
1986年 | 507篇 |
1985年 | 413篇 |
1984年 | 303篇 |
1983年 | 345篇 |
1982年 | 243篇 |
1981年 | 211篇 |
1980年 | 126篇 |
1979年 | 83篇 |
1978年 | 122篇 |
1977年 | 115篇 |
1976年 | 85篇 |
1974年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
3.
4.
5.
6.
7.
8.
9.
目的 探究高密度多孔聚乙烯植入体在鼻整形中的应用价值方法 选取2019年5月-2021年8月我院接受综合鼻整形手术的106例患者为研究对象,采用照随机数字表法分为对照组和观察组,各53例。 对照组采用自体肋骨植入术,观察组采用高密度多孔聚乙烯植入体植入治疗,比较两组临床手术指标(手术时间、恢复时间)、整形优良率、鼻指标(鼻高度/鼻长度比例、鼻唇角)、并发症发生率以及疼痛评分结果 观察组手术时间、术后恢复时间均短于对照组(P<0.05);观察组整形优良率为94.34%,高于对照组的86.79%,差异有统计学意义(P<0.05);观察组鼻高度/鼻长度比例高于对照组,鼻唇角小于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为5.66%,低于对照组的15.09%,差异有统计学意义(P<0.05);观察组疼痛评分低于对照组,差异有统计学意义(P<0.05);观察组治疗满意度为 96.23%,高于对照组的84.91%,差异有统计学意义(P<0.05)结论 高密度多孔聚乙烯植入体在鼻整形中的应用效果理想,可减轻患者疼痛度,缩短手术和恢复时间,降低并发症发生率,改善鼻高度/鼻长度比例和鼻唇角,实现理想的整形效果。 相似文献
10.
Wuteng Cao Huabin Hu Jiao Li Qianyu Wu Lishuo Shi Biao Li Jie Zhou Xinhua Wang Junhong Chen Chao Wang Huaiming Wang Weihao Deng Yan Huang Yanhong Deng 《International journal of cancer. Journal international du cancer》2023,153(11):1894-1903
Neoadjuvant programmed cell death protein 1 (PD-1) blockade exhibits promising efficacy in patients with mismatch repair deficient (dMMR) colorectal cancer (CRC). However, discrepancies between radiological and histological findings have been reported in the PICC phase II trial (NCT 03926338). Therefore, we strived to discern radiological features associated with pathological complete response (pCR) based on computed tomography (CT) images. Data were obtained from the PICC trial that included 36 tumors from 34 locally advanced dMMR CRC patients, who received neoadjuvant PD-1 blockade for 3 months. Among the 36 tumors, 28 (77.8%) tumors achieved pCR. There were no statistically significant differences in tumor longitudinal diameter, the percentage change in tumor longitudinal diameter from baseline, primary tumor sidedness, clinical stage, extramural venous invasion status, intratumoral calcification, peritumoral fat infiltration, intestinal fistula and tumor necrosis between the pCR and non-pCR tumors. Otherwise, tumors with pCR had smaller posttreatment tumor maximum thickness (median: 10 mm vs 13 mm, P = .004) and higher percentage decrease in tumor maximum thickness from baseline (52.9% vs 21.6%, P = .005) compared to non-pCR tumors. Additionally, a higher proportion of the absence of vascular sign (P = .003, odds ratio [OR] = 25.870 [95% CI, 1.357-493.110]), nodular sign (P < .001, OR = 189.000 [95% CI, 10.464-3413.803]) and extramural enhancement sign (P = .003, OR = 21.667 [2.848-164.830]) was observed in tumors with pCR. In conclusion, these CT-defined radiological features may have the potential to serve as valuable tools for clinicians in identifying patients who have achieved pCR after neoadjuvant PD-1 blockade, particularly in individuals who are willing to adopt a watch-and-wait strategy. 相似文献